Wright Medical Group N.V.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Wright Medical Group N.V.
Delivering innovation is still the driving force for medtechs intent on growing in the market, regardless of COVID-19, the disruptive effects of which have intensified with the appearance of new variants, says Jefferies Healthcare equity analyst Raj Denhoy.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
The agreements with the US Federal Trade Commission and the UK Competition and Markets Authority are the last regulatory hurdles in the way of Stryker’s planned $4bn acquisition of Wright Medical.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- BioMimetic Therapeutics
- Biotech International
- Cartiva, Inc.
- Imascap SAS
- Solana Surgical LLC
- OrthoPro, LLC
- Tornier N.V.
- WG Healthcare
- Wright Medical Group, Inc.